UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 229

Sortiert nach

YB-1: oncoprotein, prognostic marker and therapeutic target?

Biochemical journal, 2013-01, Vol.449 (1), p.11-23

2013

Volltextzugriff (PDF)

Concise Review: Bullseye: Targeting Cancer Stem Cells to Improve the Treatment of Gliomas by Repurposing Disulfiram

Stem cells (Dayton, Ohio), 2015-04, Vol.33 (4), p.1042-1046

2015

Volltextzugriff (PDF)

Identification of ROCK1 kinase as a critical regulator of Beclin1-mediated autophagy during metabolic stress

Nature communications, 2013, Vol.4 (1), p.2189-2189, Article 2189

2013

Volltextzugriff (PDF)

Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival

Cancer research (Chicago, Ill.), 2008-12, Vol.68 (24), p.10238-10246

2008

Volltextzugriff (PDF)

YB-1 Expression and Phosphorylation Regulate Tumorigenicity and Invasiveness in Melanoma by Influencing EMT

Molecular cancer research, 2018-07, Vol.16 (7), p.1149-1160

2018

Volltextzugriff (PDF)

Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion

Journal of experimental & clinical cancer research, 2023-07, Vol.42 (1), p.175-175, Article 175

2023

Volltextzugriff (PDF)

Y-Box Binding Protein-1 Induces the Expression of CD44 and CD49f Leading to Enhanced Self-Renewal, Mammosphere Growth, and Drug Resistance

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (7), p.2840-2851

2010

Volltextzugriff (PDF)

Targeting p90 Ribosomal S6 Kinase Eliminates Tumor-Initiating Cells by Inactivating Y-Box Binding Protein-1 in Triple-Negative Breast Cancers

Stem cells (Dayton, Ohio), 2012-07, Vol.30 (7), p.1338-1348

2012

Volltextzugriff (PDF)

Interplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells

Oncotarget, 2015-11, Vol.6 (35), p.38239-38256

2015

Volltextzugriff (PDF)

Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability

PloS one, 2010-09, Vol.5 (9), p.e12661

2010

Volltextzugriff (PDF)

Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes

Breast cancer research : BCR, 2008-01, Vol.10 (5), p.R86-R86, Article R86

2008

Volltextzugriff (PDF)

YB‐1 Transforms Human Mammary Epithelial Cells Through Chromatin Remodeling Leading to the Development of Basal‐Like Breast Cancer

Stem cells (Dayton, Ohio), 2014-06, Vol.32 (6), p.1437-1450

2014

Volltextzugriff (PDF)

Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice

Cancer research (Chicago, Ill.), 2008-11, Vol.68 (21), p.8661-8666

2008

Volltextzugriff (PDF)

Molecular Profiling Identifies Prognostic Subgroups of Pediatric Glioblastoma and Shows Increased YB-1 Expression in Tumors

Journal of clinical oncology, 2007-04, Vol.25 (10), p.1196-1208

2007

Volltextzugriff (PDF)

EZH2 expression is a prognostic factor in childhood intracranial ependymoma: A Canadian Pediatric Brain Tumor Consortium study

Cancer, 2015-05, Vol.121 (9), p.1499-1507

2015

Volltextzugriff (PDF)

YB-1 Bridges Neural Stem Cells and Brain Tumor―Initiating Cells via Its Roles in Differentiation and Cell Growth

Cancer research (Chicago, Ill.), 2011-08, Vol.71 (16), p.5569-5578

2011

Volltextzugriff (PDF)

Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells

Oncogene, 2005-06, Vol.24 (26), p.4281-4292

2005

Volltextzugriff (PDF)

Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2

Cancer research (Chicago, Ill.), 2006-05, Vol.66 (9), p.4872-4879

2006

Volltextzugriff (PDF)

Hierarchical Clustering Analysis of Tissue Microarray Immunostaining Data Identifies Prognostically Significant Groups of Breast Carcinoma

Clinical cancer research, 2004-09, Vol.10 (18), p.6143-6151

2004

Volltextzugriff (PDF)

Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer

BMC cancer, 2009-11, Vol.9 (1), p.410-410

2009

Volltextzugriff (PDF)

Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas

Molecular cancer therapeutics, 2009-11, Vol.8 (11), p.3024-3035

2009

Volltextzugriff (PDF)

Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer

Journal of cell science, 2008-03, Vol.121 (5), p.664-674

2008

Volltextzugriff (PDF)

Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival

Cancer research (Chicago, Ill.), 2006, Vol.66 (1), p.393-403

2006

Volltextzugriff (PDF)

Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells

Breast cancer research : BCR, 2012-02, Vol.14 (1), p.R22-R22, Article R22

2012

Volltextzugriff (PDF)

The dawn of targeted therapies for triple negative breast cancer (TNBC): a snapshot of investigational drugs in phase I and II trials

Expert opinion on investigational drugs, 2020-11, Vol.29 (11), p.1199-1208

2020

Volltextzugriff (PDF)

1 – 25 von 229

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(208)
Mit Volltextzugriff
(208)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(149)
MEDLINE
(132)
Publisher website
(81)
Journals@Ovid Full Text
(76)
Ingenta
(70)
IngentaConnect Journals
(39)
ScienceDirect
(35)
Wiley Online Library
(29)
Springer journals
(27)
Oxford journals
(18)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(16)
Nexis
(16)
Nature_系列刊
(15)
JSTOR
(14)
Oxford Journals 2020 Medicine
(13)
Wiley Online Library Full Collection 2018
(11)
Access via Taylor & Francis
(6)
Taylor & Francis
(6)
Taylor & Francis Online
(5)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

YB-1: oncoprotein, prognostic marker and therapeutic target?

Concise Review: Bullseye: Targeting Cancer Stem Cells to Improve the Treatment of Gliomas by Repurposing Disulfiram

Identification of ROCK1 kinase as a critical regulator of Beclin1-mediated autophagy during metabolic stress

Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival

YB-1 Expression and Phosphorylation Regulate Tumorigenicity and Invasiveness in Melanoma by Influencing EMT

Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion

Y-Box Binding Protein-1 Induces the Expression of CD44 and CD49f Leading to Enhanced Self-Renewal, Mammosphere Growth, and Drug Resistance

Targeting p90 Ribosomal S6 Kinase Eliminates Tumor-Initiating Cells by Inactivating Y-Box Binding Protein-1 in Triple-Negative Breast Cancers

Interplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells

Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability

Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes

YB‐1 Transforms Human Mammary Epithelial Cells Through Chromatin Remodeling Leading to the Development of Basal‐Like Breast Cancer

Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice

Molecular Profiling Identifies Prognostic Subgroups of Pediatric Glioblastoma and Shows Increased YB-1 Expression in Tumors

EZH2 expression is a prognostic factor in childhood intracranial ependymoma: A Canadian Pediatric Brain Tumor Consortium study

YB-1 Bridges Neural Stem Cells and Brain Tumor―Initiating Cells via Its Roles in Differentiation and Cell Growth

Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells

Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2

Hierarchical Clustering Analysis of Tissue Microarray Immunostaining Data Identifies Prognostically Significant Groups of Breast Carcinoma

Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer

Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas

Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer

Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival

Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells

The dawn of targeted therapies for triple negative breast cancer (TNBC): a snapshot of investigational drugs in phase I and II trials

Suchergebnisse filtern